Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimanthro-M1 1/500 Tablet PR

Prescription Icon
Prescription Required

Marketer

Silantro Pharma Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimanthro-M1 1/500 Tablet PR

Diabetic patients using the anti-diabetic medication, Glimanthro-M1 1/500 Tablet PR (a dual-medicine formulation), should adhere to prescribed dosage and timing, consistently taken with meals. Dosage adjustments are determined by individual response and blood glucose monitoring, as directed by the physician. Continuous use is crucial for effective blood sugar management; premature discontinuation can lead to dangerously elevated blood sugar, potentially resulting in kidney complications, vision loss, neuropathy, and limb amputation. This medication is only one component of a comprehensive diabetes management plan, incorporating diet, exercise, and weight control as advised by your doctor. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and trembling. Regular meals, readily available glucose sources (e.g., sugary foods or juice), and alcohol avoidance are essential for prevention. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, upper respiratory infections, and weight gain. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Patients with a history of heart disease, pregnant women, and breastfeeding mothers should consult their doctor before commencing treatment. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are necessary.

Uses of Glimanthro-M1 1/500 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimanthro-M1 1/500 Tablet PR:

Follow your physician's instructions or consult the product labeling for proper administration. Ingest Glimanthro-M1 1/500 Tablet PR with a meal.

Common Side effects of Glimanthro-M1 1/500 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimanthro-M1 1/500 Tablet PR:

Follow your physician's guidance or consult the product information leaflet for usage instructions. Administer Glimanthro-M1 1/500 Tablet PR with a meal.

How Glimanthro-M1 1/500 Tablet PR works:

Glimanthro-M1 1/500 PR tablets contain a dual antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glimanthro-M1 1/500 Tablet PR is contraindicated due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimanthro-M1 1/500 Tablet PR during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Using Glimanthro-M1 1/500 Tablet PR while breastfeeding is contraindicated due to the potential for infant toxicity. Evidence indicates the drug may harm the nursing infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Exercise caution when administering Glimanthro-M1 1/500 Tablet PR to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is recommended. For patients exhibiting severe kidney disease, Glimanthro-M1 1/500 Tablet PR is contraindicated. Close monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimanthro-M1 1/500 Tablet PR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, initiation should involve a low Glimanthro-M1 1/500 Tablet PR dose; its administration is contraindicated in cases of severe liver disease.

What if you forget to take Glimanthro-M1 1/500 Tablet PR :

Should you forget a Glimanthro-M1 1/500 Tablet PR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimanthro-M1 1/500 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimanthro-M1 1/500 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Glimanthro-M1 1/500 Tablet PR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimanthro-M1 1/500 Tablet PR and seek immediate medical attention.
Glimanthro-M1 1/500 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 DM.
Glimanthro-M1 1/500 Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimanthro-M1 1/500 Tablet PR use can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including ataxia). To mitigate these risks, annual supplemental Vitamin B12 is recommended by some researchers.
Glimanthro-M1 1/500 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimanthro-M1 1/500 Tablet PR and alcohol is unsafe. This combination can lower blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Glimanthro-M1 1/500 Table...
59
MRP 72
17% off